Asthma Spacers Market Key Drivers and Vendor Landscape Analysis by 2025


Posted September 26, 2018 by hawerr

Asthma-related disease conditions in children are preventable with awareness, timely treatment, and education.

 
Aerosol drug delivery is the most commonly used route for the management of respiratory diseases. Metered dose inhaler (MDI) is a popular mode of aerosol delivery. Metered dose inhalers are the most common type of inhalers used in asthmatic conditions. A spacer usually attached with MDI is an external device that provides better drug delivery by increasing inhalation and actuation. The major benefit of aerosol drug delivery is fast onset of therapeutic action as the drug is delivered to the target site of action. Spacers with metered dose inhalers are used to treat several respiratory diseases such as asthma, chronic obstructive pulmonary disease (COPD), and cystic fibrosis. These inhalers deliver specific quantity of drugs directly to the lungs in the form of aerosolized drug that provides rapid pharmacological action.

Read Report Overview @ https://www.transparencymarketresearch.com/asthma-spacers-market.html

There may be numerous spacer devices available in the market such as inhaler devices. Spacers can be specific in nature. Some spacers are to be used with specific MDIs only for drug delivery and should not be used with other MDIs, otherwise drug delivery may be reduced. However, choice of spacer is also important since all spacer devices are not suitable to everyone. Therefore, it should be chosen carefully according to patient’s condition. For example, large volume spacers have capacity of 750 ml, while tidal volume of baby is 50 ml. Hence, large volume spacers can be used only in adults. Therefore for babies, spacer device with MDI is the only device available to be used in treating asthma conditions. They also require devices which include masks and a valve, for controlling the inhalation and exhalation flow rates.

Asthma-related disease conditions in children are preventable with awareness, timely treatment, and education. Therefore, increase in awareness about proactive asthma management in children could be a profitable marketing opportunity in the asthma spacers market. COPD and asthma are a major concern in the U.S. and China due to high prevalence of these diseases and high number of smokers. This is likely to drive the asthma spacers market during the forecast period. In 2014, a report published by the American Lung Association stated that nearly 47% of the U.S. citizens live in counties with unhealthy levels of particulate or ozone pollution. Therefore, rise in environmental triggers is anticipated to fuel demand for asthma spacers during the forecast period.

The global asthma spacers market has been segmented based on type, distribution channel, and region. In terms of type, the market can be classified into Volumatic, Nebuhaler, Aerochamber, Babyhaler, and Fisonair. Based on distribution channel, the global asthma spacers market can be categorized into retail pharmacies, hospital pharmacies, and e-commerce. Retail pharmacies are expected to hold the largest market share due to rise in over-the-counter sale of spacers with MDIs.

The global asthma spacers market can be segmented into five key regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is expected to continue to dominate the market due to rise in awareness and high cost of asthma management. Asia Pacific is expected to account for the second largest share of the market due to high incidence of asthma in countries such as India and China. China is likely to account for the largest share of the market in Asia Pacific owing to factors such as rapidly increasing geriatric population, high levels of pollution, and improvement in diagnosis rate.

Obtain the Report Brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=39410

Major players in the global asthma spacers market include AstraZeneca plc, Boehringer Ingelheim GmbH, GlaxoSmithKline plc, Merck & Co. Inc., Fisons, and Novartis AG.

About Us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact Us

Transparency Market Research,
90 Sate Street, Suite 700,
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: [email protected]
Website: https://www.transparencymarketresearch.com/
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By Transparency Market Research
Business Address 90 Sate Street, Suite 700,
Country United States
Categories Health , Medical , News
Tags asthma spacers market
Last Updated September 26, 2018